Introduction
The TCR mediates decision-making signals at many points induced ligation of their TCR and associated co-stimulatory signals, a number of signaling events occur. These include during T cell development and response. In the thymus, successful TCRβ rearrangement is 'sensed' in association activation of tyrosine kinases like ZAP-70, Lck and Fyn (6), phosphorylation of immunoreceptor-associated tyrosine with pre-Tα chains (1-3) and the CD3 complex (4) to permit further development. Successful TCRα chain rearrangement activation motifs, especially on the CD3ε and CD3ζ chains (7), and recruitment of phospholipase Cγ (8), leading to then allows the cells to express functional TCR on the surface, which mediates the positive and negative selection signals protein kinase C and Ras activation. At another level calcium influx induces calcineurin leading to the triggering of that mold the developing repertoire (5): positive selection rescuing from and negative selection inducing programmed transcription factors c-Rel and NF-AT essential for IL-2 gene transcription (9). Other pathways triggered include those cell death. Cells that survive these selective events are exported to the periphery as mature naive T cells.
acting via adapter proteins like Grb2 and Sos, resulting in the sequential activation of Ras, Raf1 and MAP kinases, When mature peripheral T cells respond to peptide-MHC-which ultimately induce transcription factors such as c-Fos anti-mouse CD3ε (500-A2) mAb was a gift of Dr C. A. Janeway (Yale Medical School, New Haven, CT). Other mAb used were and c-Jun (10-12). The outcome of these events is proliferation and/or differentiation, as well as secretion of a variety of hamster anti-mouse TCRβ (H57-597, HB218; ATCC, Rockville, MD) and mouse anti-human CD3ε (OKT3, CRL8001; ATCC). cytokines. Successful signaling through the TCR can result in activation and proliferation. There are also differences in All mAb were used as culture supernatants. the signal requirements both for production and maintenance Immunization of 'naive' and 'memory' T cells, suggesting that their states of differentiation are distinct (13-16).
Mice were immunized in their hind footpads either with 100 µg/ mouse of ovalbumin (OVA; Sigma, St Louis, MO) or HA307-In mice transgenic (Tg) for recombined TCRα and TCRβ chains, the majority of the T cells in the peripheral repertoire 319 peptide emulsified in complete Freund's adjuvant (CFA; Difco, Detroit, MI). Seven days after immunization draining express only the Tg receptor chains, since the presence of a recombined TCR gene during development allelically inguinal and popliteal lymph nodes were dissected and singlecell suspensions prepared for T cell proliferation assays. excludes the corresponding endogenous chains (17, 18 We have investigated the peripheral T cell repertoire in were harvested and counted by scintillation spectroscopy (Betaplate; Wallac LKB Pharmacia, Turku, Finland). Results mice expressing a TCRβ transgene derived from a human T cell clone (23), since human TCRβ transgenes have been are expressed as c.p.m. Ϯ SE. When using mAb as stimuli, culture supernatants were reported to be able to substitute completely for mouse TCRβ in thymic development as well as for peripheral added to the wells in titrating doses. Wherever mentioned, recombinant IL-2 (Boehringer Mannheim India, Mumbai, alloresponsiveness (23,24). However, we report here that the apparent repertoire restriction seen in these mice is India), phorbol myristate acetate (PMA; Sigma) or the calcium ionophore A23187 (Sigma) were added in culture at indicated associated with the failure of efficient T cell activation via the human TCRβ in the absence of extensive cross-linking, concentrations. Coating of mAb onto plates was done where appropriate by immobilizing affinity-purified goat anti-mouse despite normal positive selection occurring in the thymus.
Ig or Protein A (Sigma) at 10 µg/ml in 100 µl volume as a first layer, followed after washing by appropriate mAb in titrating 
Reagents Flow cytometry
Tg mice were screened by staining blood mononuclear cells The mouse anti-human TCRβ mAb JOVI-1 used recognizes the Tg as well as 50-75% of human peripheral blood T cells with the transgene-specific mAb JOVI-1 on ice for 45 min, followed after washing by goat anti-mouse Ig-FITC (Jackson (25) and was the generous gift of Dr M. J. Owen. The hamster ImmunoResearch, West Grove, PA). For some experiments, splenic cells from Tg mice and non-Tg littermates were subjected to preliminary enrichment for T cells by passing them over nylon wool columns and then used for staining. For two-color flow cytometric analysis, cells were stained with either anti-mouse TCRβ mAb (followed by antihamster Ig-FITC; Jackson ImmunoResearch) or anti-human TCRβ mAb (followed by anti-mouse Ig-FITC; Jackson ImmunoResearch) as well as with anti-CD44-phycoerythrin (PE). For examination of T cell activation markers, the cells were either left without any treatment or stimulated with anti-CD3 or anti-TCR mAb for 48 h, separated on Ficoll-Hypaque (Pharmacia) density gradients and stained for CD4 and CD8 versus CD25 or CD44 or CD95. For staining, FITC-labeled mAb against mouse or human CD25 and PE-labeled mAb against mouse and human CD95 and mouse CD44 (all from PharMingen, San Diego, CA) were used along with biotinylated anti-CD4 and anti-CD8 antibodies followed by streptavidin-FITC or streptavidin-PE (Jackson ImmunoResearch) as appropriate. Samples were run on a flow cytometer (Bryte; BioRad, Hemel Hampstead, UK) and analyzed using FlowJo (Treestar, San Jose, CA) software.
Results
The human TCRβ transgene expressed in the Tg mice uses V β 3 and is derived from the HA307-319-specific HLA-DR1-restricted human T cell clone, HA1.7 (26, 27) . The generation and characterization of Tg mice has been reported earlier (23). With increasing age, the proportion of T cells expressing endogenous TCRβ goes up in these mice (23 and data not shown).
Human TCRβ Tg mice respond poorly to nominal antigens
Lymph node cells from Tg mice or non-Tg littermates immunized with OVA in CFA were challenged with graded doses of OVA or protein extract from Mycobacterium tuberculosis, H37Rv (generously provided by Dr R. S. Kamat, Bai Jerbai Wadia Children's Hospital, Mumbai, India) in T cell proliferation assays in vitro. The results ( Fig. 1A and B) show that non-Tg mice responded well to OVA as well as to mycobacterial proteins, while the Tg mice showed very poor responses to both. Mice were next immunized with the influenza hemagglutinin peptide, HA307-319 (kindly synthesized by Dr D. M. Salunke, National Institute of Immunology, New Delhi, India) in CFA. Figure 1 (C) shows that Tg mice showed very poor peptide-specific responses in vitro, while non-Tg littermates responded well, suggesting that the human TCRβ chain from HA1.7 was not providing the capability even for mounting an immune response against the HA307-319 peptide.
Signaling through TCRβ is deficient in Tg T cells despite normal TCR-CD3 levels
Whether natural exposure to environmental and food antigens CD3 (data not shown). A large proportion of T cells from non- Tg mice show high levels of CD44 ( Fig. 2D ) and almost all cells expressing mouse TCRβ in Tg mice also show high levels of CD44 (Fig. 2E ). In contrast, only a small minority of the human TCRβ-expressing Tg T cells show high levels of CD44 (Fig. 2F) . Thus, it appears that Tg T cells are not easily activated by natural stimuli either. very weak response despite majority of the peripheral T cells in Tg mice showing the expression of human TCRβ (23 and Fig. 2 ). Addition of irradiated human PBMC (1ϫ10 5 /well) to transgenic splenocytes did not enhance the proliferative somewhat higher in Tg than in non-Tg cells as reported earlier (23). The ability of the anti-human TCR mAb and anti-human response (Fig. 3A) . When T cells were stimulated through CD3 using an anti-CD3ε mAb (Fig. 3B) , the proliferative CD3 to trigger normal human peripheral T cells and the T cell clone HA1.7 were compared and were found to be similar responses induced by anti-mouse CD3ε were if anything ( Fig. 3C) , ruling out the possibility that the TCRβ chain of the ment shows that the size of T cells shows a correlation with the expression of the activation markers. Thus, anti-human HA1.7 TCR was specifically unable to transduce activating signals. This suggested that there may be a signaling defect TCR mAb brings about only a minor increase in the cell size of Tg T cells but anti-mouse CD3 induces a large increase specific to the TCR component of Tg T cells.
( Fig. 4J) , as do the respective anti-CD3 and anti-TCR mAb
Induction of T cell activation markers on Tg T cells by antiin non-Tg T cells (Fig. 4I) and human T cells (Fig. 4K). human TCRβ Extensive cross-linking of anti-human TCRβ rescues T cell Since addition of anti-human TCRβ mAb to Tg T cells brings proliferation in both primary and secondary Tg T cells about only minimal proliferation of T cells, we investigated if it at least induces early activation markers. Splenic cells from
Since the Tg T cells could not be efficiently triggered to express even early activation markers with anti-TCRβ mAb Tg or non-Tg mice and human PBMC were stimulated with anti-mouse CD3, anti-human CD3, anti-mouse TCRβ and antiadded in culture, we attempted to increase the TCR ligation density by using plate-coated antibody. As shown in Fig. 5 , human TCRβ antibodies for 48 h, and cells were harvested and stained for early activation markers versus CD4 and the anti-human TCRβ antibody added in culture stimulated Tg splenocytes very poorly compared to human PBMC (Fig.  CD8 together in a two-color flow cytometric analysis. Cells expressing CD4/CD8 were gated as T cells for analysis of 5A). However, when the same antibody was used in the platebound form, the Tg T cells responded very well (Fig. 5B) . activation markers. Figure 4 shows that anti-mouse CD3 mAb can up-regulate CD44 expression on Tg T cells well Neither Tg nor non-Tg T cells showed such an enhancement of response to plate-bound antibody if anti-CD3ε was used but anti-human TCR mAb does so very weakly (Fig. 4B) , whereas both anti-mouse CD3 and anti-mouse TCR mAb ( Fig. 5C and D) . Since activation requirements of naive and memory T cells are different (13-16), we examined the bring about up-regulation of CD44 (Fig. 4A ) in non-Tg T cells. Similarly, only anti-mouse CD3 mAb and not anti-human TCR activation of naive and primed Tg T cells. Thymocytes were used as a source of predominantly naive T cells. Thymocytes mAb can up-regulate CD95 and CD25 expression on Tg T cells (Fig. 4D and G respectively) , while anti-mouse CD3 and from Tg or non-Tg mice were stimulated with anti-human TCRβ antibody in culture or in the plate-coated form. There anti-mouse TCR mAb induce CD95 and CD25 expression in almost all non-Tg T cells (Fig. 4C and F) , and anti-human was no response to the antibody added in culture, but the Tg T cells responded well to the plate-bound anti-human CD3 and anti-human TCR mAb on all human T cells ( Fig. 4E  and H) . The forward scatter of T cells from the same experi-TCRβ (Fig. 6A) . Non-Tg T cells did not respond, as expected, cells by activating them through CD3 before analyzing their responses to TCR-mediated signaling. Tg or non-Tg splenocytes were activated by plate-bound anti-CD3 for 48 h, rested in medium for a further 48 h and were then stimulated with ( Fig. 7B and C) to stimulate non-Tg or Tg splenocytes. While addition of PMA had no major effect on the human TCRanti-human TCRβ. Figure 6 (B) shows that even secondary T cells from the Tg mice could not be activated by anti-human mediated proliferation of Tg T cells, addition of A23187 resulted in a significant increase in anti-human TCR-mediated TCRβ in culture, while they responded well to plate-coated anti-human TCRβ. Thus, the signaling defect in the human response in Tg T cells (Fig. 7B) , suggesting that TCRmediated signaling may be defective in calcium flux induction TCRβ-expressing Tg T cells is related to TCR cross-linking and is not related to the activation status of the T cells.
in Tg T cells.
Exogenous IL-2 and calcium ionophore can overcome the Discussion signaling defect in Tg T cells

Non-Tg and Tg splenocytes were stimulated in the presence
The selection, maturation and development of a diverse repertoire of T cells in the thymus is influenced by peptideof anti-mouse and anti-human TCR mAb respectively in the presence or absence of IL-2. Figure 7(A) shows that the loaded MHC molecules, CD4 or CD8 co-receptors as well as the diversity of the TCR themselves. For mice expressing presence of exogenous IL-2 (10U/ml) can potentiate the antihuman TCR-mediated proliferative response of Tg T cells (3-recombined TCRα and TCRβ chains as transgene, most TCR in the periphery are of transgenic origin (19) and hence the to 10-fold in different experiments), whereas the response of non-Tg splenocytes to anti-mouse TCR is only marginally repertoire is restricted to the specificity of the transgene. In contrast, T cells in mice transgenic for a single chain of the enhanced. The calcium ionophore A23187 and the phorbol ester PMA were similarly used with appropriate anti-TCR mAb TCR have been shown to express the Tg chain with many CD4 ϩ CD8 ϩ and CD4 ϩ /CD8 ϩ T cells in the Tg thymus are comparable with non-Tg thymus (data not shown and 23). This suggests that all the essential signals required for positive selection are adequately delivered by the species-hybrid TCR. It could therefore be expected that mature peripheral T cells would also respond well to TCR-mediated signals in these mice.
To explore the functional capability of peripheral T cells, mice were immunized with nominal antigens. Tg mice mounted very weak (~10,000-fold less as compared to their non-Tg counterparts) T cell responses (Fig. 1) , possibly due to the restricted TCR repertoire in these mice because of the presence of a single Tg TCRβ chain in spite of its being associated with a variety of TCRα chains. The Tg mice are on H-2 k background and HA1.7, the original T cell clone from which the human TCRβ chain has been derived, can recognize its nominal peptide HA307-319, although weakly, on I-E k (29) . It was therefore possible that Tg mice might mount efficient T cell responses to this peptide at the least, even if their T cell repertoire was otherwise limited. However, their response against HA307-319 is also negligible (Fig. 1C) , suggesting that the T cell defect in these mice may not be due to a limited T cell repertoire. Alloreactivity appears to be an intrinsic feature of the positively selected T cells and can be mediated by the mature T cell repertoire even without immunization. Therefore, a relatively restricted TCR repertoire and a failure of effective immunization (Fig. 1) may not compromise alloreactivity. While T cells from these mice have previously been shown to be able to mount alloreactive responses (23), we find that the alloreactive responses mounted by Tg T cells are quantitatively weaker by~100-fold (data not shown). This apparent discrepancy in the findings using alloresponses with these Tg mice may be due in part to the differences in genetic backgrounds, since earlier (23) the mice were in a mixed 129 (H-2 b )ϫCBA/CaJ (H-2 k ) background, while we have bred them to homogeneity on the CBA/CaJ (H-2 k ) background before use. Also, the earlier study does not provide a dose-response titration of the alloresponse and quantitative differences may therefore have been missed. T cells from these Tg mice have been shown to respond well to staphylococcal enterotoxin B (23), known to activate human V β 3-expressing cells (30) ; the relative efficiency of that activation cannot be estimated, since no comparison can be made minimal response to anti-human TCR mAb (Fig. 3A) despite retaining their ability to respond to anti-CD3 mAb (Fig. 3B) . This restricted response was not due to the inability of mouse APC to provide adequate accessory signals to the responding different complementary endogenous chains. Mice transgenic for a single chain of TCR have been shown to T cells because addition of irradiated human APC as bystander cells to these wells did not enhance the response mount alloresponses (24, 28) , an indication that the transgenic chains participate in positive selection in the thymus. In the (Fig. 3A) . These data thus suggest that the presence of this human TCRβ chain as part of the mouse TCR complex may mice used in the present study, Ͼ90% of peripheral T cells in young mice express the Tg human TCRβ chain with be responsible for deficient signaling in peripheral T cells. While these data provide one explanation for the lack of a diverse TCRα usage (23). The numbers of CD4 -CD8 -, immune responses in the Tg mice, they do not rule out the either the anti-CD3ε mAb or for human T cells (Fig. 5) . This suggests that the defect in signaling via the Tg TCRβ chain additional presence of a restricted repertoire as a result of the transgenic TCRβ chain. It is also possible that the may be related to a relative failure of oligomerization and that the defect may be localized to the transmission of signal from xenogenic origin of the TCRβ chain may be related to this hypothetical repertoire restriction and may be overcome by the TCRαβ to the CD3 complex (41) . Whether this occurs due to altered assembly of the CD3-TCR complex due to the provision of a human MHC element. However, since signaling through the TCR appears to be compromised in the conformational constraints imposed by the xenogenic origin of the TCRβ chain and whether the specific VDJ portion of Tg T cells, there is no way of examining the repertoirerestricting role, if any, of the transgenic TCRβ chain.
this transgene or its species-specific human TCR-C β region are responsible for such alteration remains to be examined. Although active immunization failed to elicit a strong immune response, the Tg mice were not found susceptible to infections However, mice expressing a single mouse TCRβ chain as a transgene have been reported to be capable of mounting an under normal housing conditions. Hence, we looked for the evidence of environmental antigenic exposure and T cell immune response against the antigenic peptide (21) as well as clearing infections such as lymphocytic choriomeningitis activation status. Increased surface levels of CD25 and CD44 as well as increase in size have been used as early virus (42) . Therefore, it is possible that the defect in these human TCRβ Tg mice may be imposed by the presence TCR-mediated T cell activation markers (31) (32) (33) . CD44 upregulation is one of the features of activated or memory T of a xeno-TCR chain. If a relative lack of TCRαβ-driven oligomerization-related signals is at the root of the defect cells (32, 34) . Unlike CD44, only recently activated T cells express the high-affinity IL-2 receptor (CD25), but neither seen here, it is quite likely that the relatively few peptide-MHC complexes presented by APC during immunization naive nor memory T cells do (35) . Up-regulation of CD25 is also seen in anergic T cells (36) . It has also been shown that, (43) (44) (45) are insufficient to activate these T cells, leading to a lack of immune responses in vivo (Fig. 1 ). This may help following signaling through the CD3-TCR complex, the size of the responding T cell increases before cell division takes explain the fact that higher densities of activating ligands, such as superantigen-MHC complexes or allo-MHC molecules, are place and in some instances of abortive signaling such an increase in cell size is still seen (37) . The induction of Fas somewhat better at activating these Tg T cells (23 and data not shown). It is thus not surprising that, even though in old (CD95) on T cells upon activation is also well known (38) . The cumulative evidence of chronic exposure of T cells to Tg mice exposed to environmental stimuli the proportions of T cells bearing endogenous TCRβ go up (and is presumably various immunogens in Tg mice was analyzed using CD44 expression on TCRβ-expressing cells. While the majority of responsible for their normal resistance to infections), practically all Tg-expressing T cells remain CD44 low , as would be the human TCRβ-expressing Tg T cells continued to show low levels of CD44, most of the endogenous TCRβ-expressing expected of naive T cells (Fig. 2) . Normally, murine splenic T cell populations are a mixture T cells in the transgenic mice showed up-regulation of CD44 (Fig. 2) suggesting that the Tg-expressing T cells may not be of naive and experienced secondary T cells, and naive T cells are known to require relatively stringent stimuli for functionally active resulting in expansion and accumulation of the endogenous TCRβ-expressing pool with age.
complete activation (16). Hence, another question was whether the inability of these Tg T cells to respond to Since human TCRβ ligation with mAb stimulated Tg T cells very weakly (Fig. 3) , we next examined if the defect in the anti-human TCRβ mAb was because all the transgeneexpressing peripheral T cells are naive and TCR cross-linking signaling seen was restricted to T cell proliferation or also extended to the induction of early activation markers on T brought about by the antibody is not adequate to trigger them. A comparison between the anti-human TCRβ mAbcells. Our data show that there is some low-level induction of each of these early activation markers by the anti-human driven responses of responding thymocytes, which can be considered predominantly naive T cells, versus secondary T TCRβ mAb in Tg T cells (Fig. 4) , but it is far weaker than that brought about by anti-CD3ε mAb or seen in human T cells. cells generated by anti-CD3 stimulation in Fig. 6 shows that the defect seen here persists in both naive and secondary So what sort of a signal is given to the Tg T cells by the antihuman TCRβ mAb? T cells from Tg mice do not seem to T cells. The precise nature of the defect of human TCRβ-mediated become anergic since they respond well to anti-CD3 after priming with anti-human TCR in vitro (data not shown). Addisignaling in Tg T cells is the obvious next issue. Since proliferation is severely compromised, failure of induction tionally, only endogenous TCR-expressing cells from Tg mice, but not transgene-expressing cells, show high levels of CD44 of IL-2 was a distinct possibility. Interestingly, IL-2 supplementation rescues the proliferative defect (Fig. 7A ), in vivo (Fig. 2) further suggesting that transgene-expressing cells hardly ever get activated in vivo, explaining increasing suggesting that failure to induce IL-2 may be one of the defects of signaling Tg T cells through human TCRβ. IL-2 numbers of endogenous TCRβ-expressing cells in Tg mice with increasing age.
induction is crucially dependent on TCR clustering (46) , raising the possibility that the human TCRβ may not allow Under normal circumstances, anti-TCR or anti-CD3 mAb induce aggregation of CD3-TCR complexes and this oligoefficient TCR oligomerization, causing failure of IL-2 induction. Further analysis of the signals capable of rescuing Tg merization is thought to be necessary for successful activation (39) . Fluid-phase mAb appear to induce this oligomerization T cells from the human TCRβ-mediated signaling defect showed that the calcium ionophore A23187 could induce by being cross-linked via the Fc receptors on APC (40) . Platecoating of the anti-human TCRβ mAb dramatically enhanced such proliferation, while PMA could not ( Fig. 7B and C) . Sustained calcium flux induction in T cells is also thought to its stimulatory capacity for Tg T cells, while this is not true of The defect appears to be related to the level of TCR oligo- 
